INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 22, 2022 at 08:34 am EDT
Share
INKON Life Technology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,089.87 million compared to CNY 1,028.88 million a year ago. Net loss was CNY 364.08 million compared to net income of CNY 148.52 million a year ago. Basic loss per share from continuing operations was CNY 0.57 compared to basic earnings per share from continuing operations of CNY 0.25 a year ago. Diluted loss per share from continuing operations was CNY 0.57 compared to diluted earnings per share from continuing operations of CNY 0.25 a year ago.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.